Company Filing History:
Years Active: 2021-2025
Title: Martina Vettoretti: Innovator in Diabetes Management
Introduction
Martina Vettoretti is a prominent inventor based in Valla di Riesse P, Italy. She has made significant contributions to the field of diabetes management through her innovative work. With a total of 3 patents, her research focuses on developing advanced models for insulin therapy optimization.
Latest Patents
One of her latest patents is titled "Individualized multiple-day simulation model of type 1 diabetic patient decision-making for developing, testing and optimizing insulin therapies driven by glucose sensors." This mathematical model simulates realistic glucose and insulin dynamics over several days for type 1 diabetes (T1D) patients. It allows for therapeutic actions, such as insulin dosing, to be driven by either self-monitoring blood glucose (SMBG) or continuous glucose monitoring (CGM). The decision-making model incorporates real-life situations and everyday patient behaviors, accounting for common errors in diabetes management. This includes miscalculations of meal carbohydrate content, early or delayed insulin administrations, and missed insulin boluses. The model can assess when CGM can safely substitute SMBG in T1D management and develop guidelines for CGM-driven insulin dosing.
Career Highlights
Martina Vettoretti is currently employed at Dexcom, Inc., where she continues to advance her research in diabetes technology. Her work is pivotal in enhancing the quality of life for individuals living with diabetes.
Collaborations
Some of her notable coworkers include Andrea Facchinetti and Giovanni Sparacino, who collaborate with her on various projects related to diabetes management.
Conclusion
Martina Vettoretti's innovative contributions to diabetes management through her patented models are shaping the future of insulin therapy. Her work exemplifies the importance of research and innovation in improving patient care.